ArticlePDF Available

Birth weight outcome of babies whose mothers are infected with Human Immunodeficiency Virus and on antiretroviral therapy at University of Maiduguri Teaching Hospital, Nigeria

Authors:
  • Federal medical centre birnin kudu Jigawa State

Abstract

Background: Low birth weight is an important risk factor for infant morbidity and mortality, especially in Sub-Saharan Africa where HIV prevalence is still high. This review focuses on the birth weight outcome of babies whose mothers are infected with HIV and on ART at University of Maiduguri Teaching Hospital (UMTH), Nigeria. Methods: A total of 90 mother-baby pairs were studied. Babies birth weights were measured using the bassinet weighing scale and data of HIV mothers that are on ART as part of prevention of mother to child transmission of HIV (PMTCT) at UMTH were obtained from their ANC hospital record. Results: There were 47 (52.2%) males and 43 (47.8%) females. Most babies 73 (81.1%) had acceptable birth weights. Of the 17 (100 %) babies with LBW, 10 (58.8%) were HIV exposed babies. Association between HIV exposed and non HIV exposed (controls) with birth weight outcome of these babies were not significant (p = 0.419). Conclusion: Majority of babies with LBW were HIV exposed whose mothers are on ART for PMTCT. Effective ART for PMTCT in pregnant mothers during ANC may have made the LBW in our babies of no significance. We therefore recommend ART to HIV pregnant women. Keywords: Maternal antiretroviral therapy, Birth weights, Babies, University of Maiduguri Teaching Hospital, Nigeria.
ISSN: 2276-7797
Birth weight outcome of
babies whose mothers are
infected with Human
Immunodeficiency Virus and
on antiretroviral therapy at
University of Maiduguri
Teaching Hospital, Nigeria
By
Jung
udu Usman
Sandabe Mustapha Kyari
Mshelbwala Bukar Simon
Umar Ibrahim Halima
Umaru Inuwa
Baba Usman Ahmadu
Greener Journal of Medical Sciences ISSN: 2276-7797 Vol. 3 (2), pp. 053-056, February 2013.
www.gjournals.org 53
Research Article
Birth weight outcome of babies whose mothers are
infected with Human Immunodeficiency Virus and on
antiretroviral therapy at University of Maiduguri
Teaching Hospital, Nigeria
1*Baba Usman Ahmadu, 2 Umaru Inuwa, 3 Umar Ibrahim Halima,
4 Mshelbwala Bukar Simon, 3 Sandabe Mustapha Kyari
and 3 Jungudu Usman.
1Department of Paediatrics, Federal Medical Centre, Yola, Adamawa, Nigeria.
2Department of Obstetrics and Gynaecology, University of Maiduguri Teaching Hospital, Borno, Nigeria.
3Department of Paediatrics, University of Maiduguri Teaching Hospital, Borno, Nigeria.
4Department of Histopathology, University of Maiduguri Teaching Hospital, Borno, Nigeria.
*Corresponding Author’s E-mail: ahmadu4u2003@yahoo.com, Phone: +2348033668948.
ABSTRACT
Background: Low birth weight is an important risk factor for infant morbidity and mortality, especially in Sub-Saharan
Africa where HIV prevalence is still high. This review focuses on the birth weight outcome of babies whose mothers are
infected with HIV and on ART at University of Maiduguri Teaching Hospital (UMTH), Nigeria.
Methods: A total of 90 mother-baby pairs were studied. Babies birth weights were measured using the bassinet weighing
scale and data of HIV mothers that are on ART as part of prevention of mother to child transmission of HIV (PMTCT) at
UMTH were obtained from their ANC hospital record.
Results: There were 47 (52.2%) males and 43 (47.8%) females. Most babies 73 (81.1%) had acceptable birth weights. Of
the 17 (100 %) babies with LBW, 10 (58.8%) were HIV exposed babies. Association between HIV exposed and non HIV
exposed (controls) with birth weight outcome of these babies were not significant (p = 0.419).
Conclusion: Majority of babies with LBW were HIV exposed whose mothers are on ART for PMTCT. Effective ART for
PMTCT in pregnant mothers during ANC may have made the LBW in our babies of no significance. We therefore
recommend ART to HIV pregnant women.
Keywords: Maternal antiretroviral therapy, Birth weights, Babies, University of Maiduguri Teaching Hospital, Nigeria.
INTRODUCTION
Human immunodeficiency virus (HIV) infection constitutes severe health problems especially in sub-saharan and
other developing countries of the world. Sub-Saharan Africa is worst hit by the global HIV burden, with 25.4 million
people living with the disease (Chigozie, Dochka, and Treasure 2009). Reproductive age women make up half of the
total number of adult living with HIV in this region and constitute more than 50% of the world’s HIV-infected women
(Dabis and Ekpini 2002; WHO 2004). This could be of public health importance because the sub-region has a high
fertility rate and many of these women could have pregnancies complicated by HIV (WHO, 2006). Human
immunodeficiency virus infection may have severe effects on pregnant women, and could result to low birth weight
(LBW) outcomes in babies (Scott, Cumberland, and Shulman 2005). In (2009), Chigozie et al in south-eastern
Nigeria reported that LBW in HIV exposed babies, that is, babies whose mothers had HIV possibly was due to
intrauterine growth retardation (IUGR) or prematurity. The LBW effect appears to relate to impaired nutrient transport
to the foetus because the placenta could also be damaged by HIV. In support of this, Scott et al in Kenya, (2005)
documented that immune complex formation in HIV infection could impair placenta transfer of substances in mother-
foetal pair, which may lead to IUGR. In contrast, however, some workers argued that the mechanisms by which HIV
leads to LBW remain unclear (Castetbon, Ladner, and Leroy 1999).
Greener Journal of Medical Sciences ISSN: 2276-7797 Vol. 3 (2), pp. 053-056, February 2013.
www.gjournals.org 54
Previously conducted research has revealed that infant mortality is three times higher for LBW babies than
for those of normal weight, and the effect of this triples during the neonatal period (CDC, 1993; Guyatt and Snow,
2001). Antiretroviral therapy (ART) uptake which is now part of Prevention of mother to child transmission of HIV
(PMTCT) approach has increased to 6% in Nigeria and up to 17% for the African continent (WHO, 2006). Despite
this, extensive literature search on the association of HIV in mothers that are on ART and birth weight outcomes of
their babies in Nigeria showed dearth of information due to scarcity of population-based data. The objective of this
current study was to assess the birth weight outcome of babies whose mothers are infected with HIV and on ART at
University of Maiduguri Teaching Hospital (UMTH), Nigeria.
MATERIAL AND METHODS
Study site: The study was carried out at the Department of Paediatrics and Obstetrics unit of the University of
Maiduguri Teaching Hospital (UMTH), Nigeria. The UMTH is a tertiary centre located in North-Eastern Nigeria and a
centre of excellence for infectious diseases and immunology. It also serves as a referral site for the six North-Eastern
States and neighboring countries of Chad, Cameroon and Niger Republics (Ampofo, and Omotara 1987).
Study design: The study was a hospital-based randomized descriptive comparative study of mother-baby pairs
recruited from the labour ward of the UMTH.
Study population: Mother-baby pairs who met the following inclusion criteria were recruited: HIV mothers who are
on ART that gave birth at the labour ward of UMTH, babies of these mothers and with informed consent given by the
parent. Control subjects for this study included non- HIV mother-baby pairs at birth in UMTH labour ward. Mothers
with multiple pregnancies, significant antepartum hemorrhage, preterm, and stillbirth or from whom informed consent
was not obtained, were excluded.
Ethical Issues: The study protocol was reviewed and authorised by the Medical Research and Ethics Committee of
UMTH. Parents had unlimited liberty to deny consent without any consequences while confidentiality was
maintained.
Sample Size and collection of specimens
The minimum sample size was determined using statistical formula that computes 5.4% prevalence for HIV at 95
confidence interval and alpha levels of 0.05 (Naing, Winn, and Rusli 2006; WHO, 2006). This equalled 80; however,
10% of this was added to maximize power. Therefore, the sample size for this study was ninety, which comprises 45
HIV mother-baby pairs and 45 non HIV mother-baby pairs (controls).
Mother-baby pairs were enrolled in this study using the systematic random sampling method where the first of
every three mother-baby pairs were picked at the labour ward. Where the first mother-baby pair did not fulfil the
inclusion criteria the immediate next mother-baby pair that qualified was selected. On enrolment of the mother-baby
pairs, study proforma were administered to the mothers to collect information on their bio-data, pregnancy history
and antenatal care (ANC) history. Data of HIV mothers that are on ART as part of prevention of mother to child
transmission of HIV (PMTCT) at UMTH were obtained from their ANC hospital record. Babies’ birth weights in
Kilogram (kg) were measured using the bassinet weighing scale with a sensitivity of 50gms set at zero mark. Babies
weighing < 2.5 (kg) were considered LBW and those 2.5 (kg) were considered to have acceptable birth weights in
this study, similar to a publication elsewhere (Guyatt, and Robert 2004).
Data analysis: The data obtained from the study were entered into a computer for statistical analysis using SPSS
statistical software version 16, Illinois, Chicago USA. Values were expressed as percentage, mean standard
deviation (SD). Chi-squared (χ2) test was used as appropriate to determine associations for qualitative variables. A p
value < 0.05 was considered significant. Tables were used appropriately for illustrations.
RESULTS
Ninety mother-baby pairs were enrolled into this study, out of which 45 (50%) of the babies had their mothers
infected with HIV, thereby making them to be HIV exposed. The remaining 45(50%) babies were controls from non-
HIV exposed mothers. Majority of the babies 47 (52.2%) were males table 1. The male to female ratio is 1.09:1.
Greener Journal of Medical Sciences ISSN: 2276-7797 Vol. 3 (2), pp. 053-056, February 2013.
www.gjournals.org 55
Table 1. Sex distribution of the babies
Sex
Frequency
Percentage (%)
Male
47
52.2
Female
43
47.8
Total
90
100
All HIV infected mothers during the course of ANC received ART for PMTCT. Mean maternal age was 23.87 ± 5.31
(95% CI, 22.76 24.98) year, and the overall mean birth weight of babies was 3.01 ± 0.60 (95% CI, 2.88 3.13).
Overall mean weight for LBW babies was 2.08 ± 0.35 (95% CI, 1.90 – 2.26) kg and that for HIV exposed babies was
2.23 ± 0.18 (95% CI, 2.09 – 2.36) kg.
Most babies in this study 73 (81.1%) had acceptable birth weights (table 2). Of the 17 (100 %) babies with
LBW, 10 (58.8%) were HIV exposed babies. Association between HIV exposed and non- HIV exposed (controls) with
birth weight outcome of these babies were insignificant (p = 0.419).
Table 2. Birth weight distribution of HIV exposed and non- HIV exposed babies
BW (kg)
HIV exposed babies
n (%)
Non HIV exposed
n (%)
Total
LBW
10 (11.1)
7 (7.8)
17 (18.9)
ABW
35 (38.9)
38 (42.2)
73 (81.1)
Total
45 (50)
45 (50)
90 (100)
BW= Birth weight LBW= Low birth weight ABW= Acceptable birth weight HIV = Human immunodeficiency virus
DISCUSSION
The proportions of babies with low birth weight in this study were higher in HIV exposed than non- HIV exposed
(control) babies, even though this was not significant. Similar observation was made by colleagues in Kenya (Scott et
al, 2005). Because all HIV infected mothers in this study were receiving ART as part of PMTCT during ANC, this
could have improved their CD4 count and at the same time reduced their viral load burden. As such, the adverse
effects of HIV on foetal birth weight may have been curtailed. It was noted in another study that a low proportion of
LBW which may be insignificant could occurred among babies born to mothers who did ANC (Chigozie et al, 2009).
This finding could suggest the efficacy of chemoprophylaxis, which includes ART in the case of HIV infected mothers
that are usually administered during ANC for PMTCT. This approach would lead to the overall improvement of birth
weight outcome by reducing LBW prevalence and increasing the median birth weight of babies (Chigozie et al,
2009).
Interestingly, studies conducted in Rwanda and Zimbabwe have revealed that the proportion of LBW is
considerably higher among mothers infected with HIV than in those without HIV infection (Castetbon et al 1999;
Ticconi, Mapfumo, and Dorrucci 2003). In yet another study conducted in Kigali, LBW is significantly more frequent in
full-term infants born to HIV-positive mothers than to HIV-negative mothers (Leroy, Ladner, and Nyiraziraje 1998).
These results underscore the need for ART in HIV infected pregnant mothers for PMTCT during ANC, hoping to
improve the birth weight outcome of babies in these mothers.
Greener Journal of Medical Sciences ISSN: 2276-7797 Vol. 3 (2), pp. 053-056, February 2013.
www.gjournals.org 56
CONCLUSION
Majority of babies with LBW were HIV exposed whose mothers are on ART for PMTCT. Effective ART for PMTCT in
pregnant mothers during ANC may have made the LBW in our babies of no significance. We therefore recommend
ART to HIV pregnant women.
REFERENCES
Ampofo K, Omotara BA. (1987). Epidemiology of measles in Borno State. Annals of Borno 4,pp 217-227.
Castetbon K, Ladner J, Leroy V. (1999). Low birth weight in infants born to African HIV-infected women: relationship
with maternal body weight during pregnancy: Pregnancy and HIV Study Group (EGE). Journal of Tropical
Pediatrics 45(3), pp152- 157.
Chigozie JU, Dochka DD, Treasure NU. (2009). Effects of Maternal Plasmodium falciparum Malaria and HIV infection
on Birth Weight in Southeastern Nigeria. MJM 12(2), pp. 42-49.
Dabis F, Ekpini ER. (2002). HIV-1/AIDS and maternal and child health in Africa. Lancet 359,pp.2097–2104.
Guyatt H L, Snow RW. (2001). Malaria in pregnancy as an indirect cause of infant mortality in sub-Saharan Africa.
Transactions of the Royal Society of Tropical Medicine and Hygiene 95,pp 569-576.
Guyatt HL, Robert WS. (2004). Impact of Malaria during Pregnancy on Low Birth Weight in Sub-Saharan Africa.
Clinical Microbiology Reviews 17 (4),pp 760–769.
Leroy V, Ladner J, Nyiraziraje M. (1998). Effect of HIV-1 infection on pregnancy outcome in women in Kigali,
Rwanda, 1992-1994. Pregnancy and HIV Study Group, AIDS 12,pp 643-650.
Mangochi Malaria Research Project. (1993). Malaria prevention in pregnancy: the effects of treatment and
chemoprophylaxis on placental malaria infection, low birth weight, and fetal, infant, and child survival. U.S.
Agency for International Development in conjunction with Centers for Disease Control and Prevention, Atlanta,
Ga.
Naing L, Winn T, Rusli BN. (2006). Practical Issues in Calculating the Sample Size for Prevalence Studies. Archives
of Orofacial Sciences 1,pp 9-14.
Scott S, Cumberland P, Shulman CE. (2005). Neonatal measles immunity in rural Kenya: the influence of HIV and
placental malaria infections on placental transfer of antibodies and levels of antibody in maternal and cord serum
samples. J Infect Dis 191,pp.1854–1860.
Ticconi C, Mapfumo M, Dorrucci M. (2003). Effect of maternal HIV and malaria infection on pregnancy and perinatal
outcome in Zimbnabwe. Journal of Acquired Immune Deficiency Syndrome 34,pp 289-294.
World Health Organisation. (2006). Country health system fact sheet Nigeria.
World Health Organization (WHO). (2004). AIDS epidemic update. Geneva, UNAIDS/WHO.
... Complications of early pregnancy have also been associated with HIV infection in several studies [4,5,7,8]. HIV-1 and HIV-2 infection in Africa have both been linked to a higher rate of spontaneous abortion 1 . However, the impact of HAART was not determined, which is also beyond the scope of this study as to determine the impact of ART on the pregnancy outcome. ...
... Other studies in predominantly asymptomatic cohorts have shown no significant difference in birth weights such as a study conducted in North-Eastern Nigeria by Ahmadu., et al. [8] it was a hospital-based randomized descriptive comparative study on birth weight outcome of babies whose mothers were infected with H I V times more likely to deliver a low-birth-weight baby; especially in the presence of HIV-related symptoms [4]. In view of the available literature, symptomatic HIV infection is more likely than not to be associated with low birth weight, however, in asymptomatic HIV infection is as yet inconclusive. ...
... The slightly higher rate of LBW among HIV-unexposed neonates is contrary to some previous reports. 14,15,22,23 In some African studies, HIV-exposed neonates were found to have up to 3 fold higher risk of low birth developing countries due to poverty and inadequate ante-natal care. On the contrary, there is often little or no difference in the fetal outcomes between HIV-infected and uninfected mothers in developed countries with better quality of antenatal care and HIV management. ...
Article
Full-text available
Background: HIV infection in pregnant women is a known cause of low birth weight (LBW) and small for gestational age (SGA). This study compared the birth weight for gestational age (GA) of HIV exposed and non-exposed babies in Nnamdi Azikiwe University Teaching Hospital, (NAUTH) Nnewi, Nigeria. Subjects and methods: A retrospective comparative appraisal of birth weights for GA of babies born to HIV- positive and negative women, over a 7-year period (January 2009-December 2015), was conducted. Data were abstracted from PMTCT database, ANC and Labor ward registers of NAUTH. Results: A total of 3459 babies (1782 males, 1677 females) were enrolled, out of which 1829 were HIV- exposed and 1630 were not. GA spanned from 26-42 weeks (mean 38.7 ± 2.2 weeks) and birth weights (BW) from 400-5300g (mean 3072.5 ± 630g). The mean BW of exposed babies was significantly lower than the unexposed babies (p=0.048). LBW occurred in 12.0% of exposed and 13.5% of non-exposed babies (p<0.001). Using either percentile or Z-score cut-offs, HIV-exposed babies had twice the proportion of SGA compared to their non-exposed counterparts. Using Z-score, maternal antiretroviral use for >5 years was significantly associated with the lowest proportion of SGA compared to shorter duration of use. Conclusion: Maternal HIV infection is associated with SGA. However, maternal ARV use in excess of 5 years is associated with better BW outcome. Targeted enhancement of maternal nutrition and strict adherence to ARV therapy prior to and during pregnancy will improve birth outcome.
... The pregnancy outcome in HIV infection remains skewed with poor outcome reported mainly from developing countries. Townsend et al., (2007) reported 14.1% preterm delivery rate in the UK, Ahmadu et al., (2013) reported LBW rate of 22.2% in Maiduguri while Akabuike et al., (2010) reported 21.6% in Nnewi, Nigeria. Aniji et al., (2013) reported no difference in preterm delivery and LBW while Patel et al., (2010) reported no difference in preterm delivery in pre and post conception commencement of antiretroviral. ...
Article
Full-text available
Pregnancy outcomes in HIV positive women remain a concern especially in sub-Saharan Africa which bears the highest burden of the disease. To evaluate pregnancy outcomes in booked preg-nant women on Highly Active Antiretroviral Therapy (HAART) at the University of Ilorin Teach-ing Hospital (UITH), Ilorin, Nigeria; a case control study (with women initiating HAART in preg-nancy as subjects and those who initiated it before pregnancy as control) of 268 HIV-positive wom-en managed between March 2009 and February 2013 was undertaken at the hospital. Inclusion cri-teria comprised HIV-positivity, booking, antenatal care and delivery at the study site. From the total of 8,958 women who had antenatal care during the period, 502 had HIV infection (prevalence 5.6%) out of which 268 satisfied the inclusion criteria and were enrolled into the study. Subjects were 54(20.2%) while 214(79.8%) were controls; the mean age of participants was 31.0±4.5 years while mean parity was 2.0±1.5. Pregnancy outcomes were worse in subjects with statistical signifi-cance in miscarriage (11.1% vs. 0.9%; OR 11.78, 95% CI 2.07-87.03, p <0.01), preterm delivery (31.5% vs. 1.9%; OR 24.35, 95% CI 7.15-91.26, p<0.01), term pregnancy (42.6% vs. 96.3%; OR 0.03, 95% CI 0.01-0.08, p<0.01), birth asphyxia (OR 8.31, 95% CI 3.25-21.45 p<0.01), low birth weight babies (OR 260.0, 95% CI 66.51-1142.77, p<0.01) and maternal puerperal complications (anaemia 35.2% vs. 0.9%; OR 68.79, 95% CI 14.28-452.19, p <0.01). Mother to child transmission of HIV was recorded in only 3(1.1%) babies among the subjects. Commencement of HAART before pregnancy appears to improve pregnancy outcomes in HIV positive women.
Article
Full-text available
The effects of malaria and HIV infection on birth weight were assessed among 300 women in childbirth in Southeastern Nigeria using standard techniques. Prevalence of maternal Plasmodium falciparum malaria infection was 16.0%. Individuals of younger age, primigravidae, anemic (with Hgb <11.0g/dl) and those who had never attended antenatal clinic (ANC) were more likely to have malaria infection. Prevalence of HIV infection was 3.6% and malaria prevalence was significantly higher among HIV-positive than HIV-negative women (37.5%, 95% CI, 4.0-71.0% versus 14.3%, 95% CI., 9.6-19.0%), (χ2 =13.3, P<0.05). Malaria-infected women had a significantly higher proportion of lBW babies than the uninfected (F-ratio=15.05, P<0.05). A higher proportion of low birth weight (lBW) was recorded among anemic women, primigravidae and those who never attended ANC. lBW babies were significantly higher among HIV-positive than HIV-negative women (25.0% vs 16.6%), (F-ratio=130.8, P<0.05). Malaria and HIV interventions via ANC are crucial for reduction of their adverse effects on pregnancy outcome.
Article
Full-text available
The sample size calculation for a prevalence only needs a simple formula. However, there are a number of practical issues in selecting values for the parameters required in the formula. Several practical issues are addressed and appropriate recommendations are given. The paper also suggests the application of a software calculator that checks the normal approximation assumption and incorporates finite population correction in the sample size calculation.
Article
Full-text available
Malaria during pregnancy can result in low birth weight (LBW), an important risk factor for infant mortality. This article reviews the pathological effects of malaria during pregnancy and the implications for the newborn's development and survival. Empirical data from throughout Africa on associations between placental malaria and birth weight outcome, birth weight outcome and infant mortality, and the rates of LBW in areas with various levels of malaria transmission are evaluated to assess the increased risks of LBW and infant mortality associated with malaria. It is estimated that in areas where malaria is endemic, around 19% of infant LBWs are due to malaria and 6% of infant deaths are due to LBW caused by malaria. These estimates imply that around 100,000 infant deaths each year could be due to LBW caused by malaria during pregnancy in areas of malaria endemicity in Africa.
Article
Full-text available
Young infants are protected from measles infection by maternal measles antibodies. The level of these antibodies at birth depends on the level of antibodies in the mother and the extent of placental transfer. We investigated predictors of levels of measles antibodies in newborns in rural Kenya. A total of 747 paired maternal-cord serum samples (91 from human immunodeficiency virus [HIV]-infected and 656 from HIV-uninfected mothers) were tested for measles immunoglobulin G antibodies. Placental malaria infection was determined by biopsy. Data on pregnancy history, gestational age, and anthropometric and socioeconomic status were collected. Infants born to HIV-infected mothers were more likely (odds ratio, 4.6 [95% confidence interval {CI}, 2.2-9.7]) to be seronegative and had 35.1% (95% CI, 9.8%-53.2%) lower levels of measles antibodies than did those born to HIV-uninfected mothers. Preterm delivery, early maternal age, and ethnic group were also associated with reduced levels of measles antibodies. There was little evidence that placental malaria infection was associated with levels of measles antibodies in newborns. Our results suggest that maternal HIV infection may reduce levels of measles antibodies in newborns. Low levels of measles antibodies at birth render children susceptible to measles infection at an early age. This is of concern in sub-Saharan African countries, where not only is the prevalence of HIV high, but measles is the cause of much morbidity and mortality.
Article
To study the effect of HIV-1 infection on pregnancy outcome in women provided with antenatal services including malaria and sexually transmitted disease (STD) treatment in Kigali, Rwanda. Pregnant women attending the antenatal clinic ward of the Centre Hospitalier de Kigali in their last 3 months of pregnancy were tested for HIV antibody after consent had been obtained. All HIV-1-infected women were included and compared with HIV-negative women of same age and parity. Until delivery, each woman enrolled had a monthly follow-up including malaria and STD aetiological diagnosis and treatment. At the time of delivery, obstetrical and neonatal characteristics were recorded. Mothers and their children were followed until 6 weeks postpartum. By mid-August 1993, 384 HIV-positive and 381 HIV-negative women had been enrolled and by the end of November 1993, 729 women (95.3%; 364 HIV-positive and 365 HIV-negative) had delivered 725 livebirths, including eight and six twins, respectively; 10 stillbirths were recorded amongst HIV-positive women and eight amongst HIV-negative women (P=0.60). Excluding twins, premature birth (< 37 completed weeks of gestation) was observed in 22.7% of infants born to HIV-positive women versus 14.1% of those born to HIV-negative women; low birth weight (< 2500 g) was observed in 25.5% of infants born to HIV-positive women versus 14.8% of those born to HIV-negative women. Low birth weight was significantly more frequent in full-term infants born to HIV-positive mothers than to HIV-negative mothers. No significant difference in low birth weight rate was observed in preterm infants. Death occurred in 5.1% of children during the perinatal period without statistically significant difference between the two groups. HIV-positive women were more likely to have a postpartum haemorrhage. In the context of high HIV prevalence, maternal HIV infection is associated with adverse obstetrical and neonatal outcomes even when treating STD and malaria.
Article
The effect of maternal HIV infection on birthweight was estimated. In the prenatal clinic of the Centre Hospitalier de Kigali, HIV screening was proposed to women with a gestational age (GA) of less than 28 weeks. HIV-infected (HIV+) and uninfected (HIV-) women were recruited, when they consented. At inclusion, socioeconomic, obstetrical data, and body weight were collected, a clinical examination was performed, and tests for sexually transmitted diseases (STDs) and malaria were performed. Two prenatal visits were made, at 28-32 and 32-36 weeks, with clinical data and weight measurement. At delivery, birthweight, body length, and head circumference of the infant were documented. At inclusion and at the second follow-up visit, HIV+ women (N = 177) weighed less than HIV- women (N = 194) (p = 0.004). Mean birthweight in infants born to HIV+ women was 2947 g (SD = 429) and 3104 g (SD = 461) in infants born to HIV- women (p = 0.001). Frequencies of low birthweight (LBW, weight < 2500 g), prematurity (GA < 37 weeks, according to Finnström score at birth), and intrauterine growth retardation (defined by LBW and GA > or = 37 weeks) were higher in infants born to HIV+ women than to HIV- women (p = 0.009, 0.01, and 0.053, respectively). In multivariate logistic regression, the association between maternal HIV infection and LBW disappeared (p = 0.61), while low GA (p = 0.01) and low last prenatal weight (p = 0.01) were independant risk factors of LBW. LBW in infants born to HIV+ women could be partly attributable to impaired maternal weight. These results underline the need for nutritional surveillance and dietary counselling, hoping to improve the prognosis of pregnancy in HIV+ women, regardless of other therapeutic interventions.
Article
Although randomized controlled trials of interventions to reduce malaria in pregnancy have demonstrated an increase in the birthweight of the newborn in primigravidae, the subsequent impact on infant mortality in all-parities has not been assessed. The aim of this paper was to model the possible impact of placental malarial infection on infant mortality through reduced birthweight. An extensive literature search was undertaken to define a series of parameters describing the associations between placental infection, birthweight and premature mortality in sub-Saharan Africa. It was shown that a baby is twice as likely to be born of low birthweight if the mother has an infected placenta at the time of delivery (all-parities: 23% vs 11%, primigravidae only: 32% vs 16%), and that the probability of premature mortality of African newborns in the first year of life is 3 times higher in babies of low birthweight than in those of normal birthweight (16% vs 4.6%). Assuming 25% of pregnant women in malaria-endemic areas of Africa harbour placental malarial infection, it is suggested that 5.7% of infant deaths in malarious areas could be an indirect cause of malaria in pregnancy. This would imply that, in 1997, malaria in pregnancy could have been responsible for around 3700 infant deaths under the diverse epidemiological conditions in Kenya. Placental infection with Plasmodium falciparum appears to have a more significant role in infant survival in Africa than has been previously assumed. This may explain the high reduction in infant mortality rates from interventions aimed at reducing transmission, over and above that expected from a decline in direct malaria-specific mortality alone.
Article
Every day, 1900 children acquire HIV-1 infection from their mother in Africa. The 25-45% risk of mother-to-child transmission can be reduced in several ways: prevention of sexual transmission for women of child-bearing age, access to HIV-1 testing, reduction of unwanted pregnancies by education of HIV-1-infected women, and antiretroviral-based prevention. All antiretroviral regimens of proven efficacy can be used in a minimum package of care for HIV-1-infected pregnant women. At present, programmes in 13 countries reach less than 3% of HIV-1-infected African women. 35-59% of African children infected with HIV-1 die by their second birthday. Infectious complications are preventable by primary prophylaxis with co-trimoxazole. A rapid scaling-up and comprehensive continuum of care is needed for all members of affected families, including access to antiretroviral treatment and community-based responses to the increasing number of orphans. Prevention of mother-to-child transmission should become a universal standard of care in Africa, and research should continue to reduce the transmission risk to well below 5%.
Article
To investigate the effect of isolated or concomitant infection with malaria and HIV on pregnancy and neonatal outcome. Data were collected on pregnant women admitted during the rainy seasons in the obstetric division of a district referral hospital in northern Zimbabwe in 2000 and 2001. The effects of malaria and HIV infection were determined by multivariate analysis. The prevalence of HIV seropositivity and symptomatic malaria in 986 pregnant women was 8.3% and 14.7%, respectively. HIV-infected women were more likely to develop malaria attacks during pregnancy than seronegative women (odds ratio [OR] = 3.96, 95% confidence interval (CI): 2.42-6.46). Malaria and HIV infections were associated with increased risk of stillbirth (OR = 4.74, 95% CI: 1.34-16.78) and preterm delivery (OR = 4.10, 95% CI: 2.17-7.75), respectively. They were independently associated with increased risk of low birth weight (malaria: OR = 10.09, 95% CI: 6.50-15.65; HIV: OR = 3.16, 95% CI: 1.80-5.54) and very low birth weight (malaria: OR = 5.04, 95% CI: 1.00-25.43; HIV: OR = 10.74, 95% CI: 2.12-54.41), low Apgar score (malaria: OR = 4.45, 95% CI: 1.42-13.94; HIV: OR = 5.94, 95% CI: 1.66-21.30), and fetal growth restriction (malaria: OR = 3.98, 95% CI: 2.51-6.30; HIV: OR = 4.07, 95% CI: 2.40-6.92). Dual infection with malaria and HIV was associated with increased risk of maternal, perinatal, and early infant death. Women with single HIV or malaria infection have a significantly increased risk of adverse outcomes of pregnancy and childbirth. Dual infection has additional detrimental effects on maternal and infant survival in an area where HIV and malaria coexist.
Malaria prevention in pregnancy: the effects of treatment and chemoprophylaxis on placental malaria infection, low birth weight, and fetal, infant, and child survival. U.S. Agency for International Development in conjunction with
Mangochi Malaria Research Project. (1993). Malaria prevention in pregnancy: the effects of treatment and chemoprophylaxis on placental malaria infection, low birth weight, and fetal, infant, and child survival. U.S. Agency for International Development in conjunction with Centers for Disease Control and Prevention, Atlanta, Ga.